K.-W. Lee - Concepedia

Author

K.-W. Lee

Seoul National University Bundang Hospital

Also Known As

K.-W. Lee, Kyoung-nam Lee

Publications

594

Citations

H-Index

Concepts

All Affiliations

Seoul National University Bundang Hospital Samsung Medical Center Asan Medical Center National Cancer Center Hospital East Kindai University

About

K.-W. Lee is an author at Seoul National University Bundang Hospital specializing in oncology, cancer therapeutics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	127
2	Health Sciences	1	1	71
3	Cell Biology	1	1	11
4	Immunology	1	1	11
5	Pharmacology	1	1	26

K.-W. Lee

Publications

566

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4) Narikazu Boku, Min‐Hee Ryu, Ken Kato, Annals of Oncology	2018	317
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer Kohei Shitara, Tania Fleitas, Hisato Kawakami, ESMO Open	2024	73
Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens Yoon‐Koo Kang, W. Kang, Maria Di Bartolomeo, Annals of Oncology OncologyGastrointestinal OncologyCancer ManagementClinical TrialsAdvanced/metastatic Gastric Cancer	2019	71
Irinotecan Combined with 5-Fluorouracil and Leucovorin as Second-line Chemotherapy for Metastatic or Relapsed Gastric Cancer Min‐Duk Seo, K.-W. Lee, Juwon Lim, Japanese Journal of Clinical Oncology	2008	37
Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer Hye Jung Chang, K.-W. Lee, Jee Hyun Kim, Annals of Oncology Elderly PatientsGastrointestinal OncologyMedicineCancer ManagementPharmacology	2011	26
Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma progressed after platinum-based therapy or platinum ineligible Manish R. Patel, John Ellerton, Manish Agrawal, Annals of Oncology Platinum-based TherapyUrologyMetastatic Urothelial CarcinomaGenitourinary CancerMedicine	2016	19
A phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data Taroh Satoh, L.-T. Chen, Yoon‐Koo Kang, Annals of Oncology	2018	12
Safety, anti-tumour activity, and biomarker results of the HER2-targeted bispecific antibody ZW25 in HER2-expressing solid tumours Do‐Youn Oh, Erika Hamilton, Diana L. Hanna, Annals of Oncology Breast OncologyMedicineImmunologyAnti-tumour ActivityBiomarker Results	2019	11

Page 1